[Pharmacological aspects of darunavir/cobicistat]

Enferm Infecc Microbiol Clin. 2016 May:34 Suppl 1:30-33. doi: 10.1016/S0213-005X(17)30006-X.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Cobicistat / pharmacokinetics
  • Cobicistat / therapeutic use*
  • Darunavir / pharmacokinetics
  • Darunavir / therapeutic use*
  • Drug Combinations
  • Drug Interactions
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • HIV Protease Inhibitors / pharmacokinetics
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Ritonavir / pharmacokinetics
  • Ritonavir / therapeutic use

Substances

  • Drug Combinations
  • HIV Protease Inhibitors
  • Cobicistat
  • Ritonavir
  • Darunavir